Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-26 @ 12:06 AM
Study NCT ID:
NCT00408694
Status:
COMPLETED
Last Update Posted:
2018-01-30
First Post:
2006-12-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-06
First Submit QC Date:
None
Study First Post Date:
2006-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-01
Results First Submit QC Date:
None
Results First Post Date:
2013-04-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-04
Last Update Post Date:
2018-01-30
Last Update Post Date Type:
ACTUAL